I have spoken to a member of Kerx mgmt staff. They are extremely optimistic on Kerx's future and in talks with potential partners.
AF compared Avnr patent issue to Kerx's. There are parts of Neudexta that's Patented that AF
did not disclose and parts that's not. It's made in part from cough medicine existing patent but the new part of Neudexta is patented. Anyway, Avnr prevailed without a partner and continues to do fine today, with sales of Neudexta increasing. Avnr was a small biotech with one small drug on the market ABREVA AND BIG PHARMA WERE NOT INTERESTED. That's my assumption of the matter back then. Plus, they had several Fda rejections.
Just to add, Avnr took on staff of 200, instead of outsourcing that was and remains costly today. I will call Kerx and recommend to mgmt to outsource Zerenex.
To be honest with you all, I help Avnr for 5 years and made a profit.
What a fraud? Now, you all know Gale has been open to holders and Ahn has delivered. Now, Schwartz and SA trying to mess Gale up cause they greed., shorts/ optionee.
Dr. Ahn has expressed his concerns for patients and holders. All I have to say buy if it drops.
You donot make money as the preferred may sit for years, no dividend and small increase in pps.
That should be reflected based on ph3, Awaiting Partners are reviewing ph3.
Awaiting new Patents soon.
Awaiting Predialisyis from Japan soon.
The firm has value and must not trade belown $8.50.
Good luck !!!
I believe you. Spoke to IR and they were confident in approval and future of zgnx
Exactly, that's a part of the game plan. I have emails and spoke to Dr. Ahn asked questions that he did not comment on. Why, it relates to insider information so that's the pixx off with SA and Street.
Tcell therapy, Bloomberg.
but you all have time down in Cali laying out in the sun and playing golf while holders suffer. Well boys, the fun stops here.